| Page 1015 | Kisaco Research

Model Risk - ESG Testimonial 5


The conference was rich in content and attendees, representing industry professionals and service providers. The intimacy of the conference allowed for thoughtful and intriguing perspectives, impactful dialogue, and valuable connections.

Model Risk - ESG Testimonial 4

Without knowing what to expect, I came away with a wide array of knowledge, best practices, and practical applications that will help my organization.

Model Risk - ESG Testimonial 3

Each session was rich in content with relevant representation of industry professionals in the banking space. The setting and size of the conference allowed for meaningful conversations and practical connections.

Model Risk - ESG Testimonial 2

Fantastic experience. The attendees, participants, content, and overall dialogue offered priceless insights into how thought leaders are blazing new trails in risk assessment, management, disclosure, and reporting as they confront the challenges of climate change.

Model Risk - ESG Testimonial 1


The summit presented thought-provoking speakers with practical insights (beyond just theory), panel discussions were well-rounded with salient topics and it was a great opportunity to meet with others in the industry and share best practices

 

Yong Cang

Co-Founder & CSO
Degron Therapeutics

Yong Cang

Co-Founder & CSO
Degron Therapeutics

Yong Cang

Co-Founder & CSO
Degron Therapeutics
 

Ted Suh

VP, Chemistry
Orionis Biosciences

Ted Suh

VP, Chemistry
Orionis Biosciences

Ted Suh

VP, Chemistry
Orionis Biosciences
 

Simon Bailey

Simon Bailey

Simon Bailey

 

Scott Kanner

Co-Founder, Associate Director, Platform Development
Stablix

Scott Kanner

Co-Founder, Associate Director, Platform Development
Stablix

Scott Kanner

Co-Founder, Associate Director, Platform Development
Stablix